Adamis Pharmaceuticals (ADMP) Stock Forecast, Price & News

Adamis Pharmaceuticals' stock was trading at $11.8510 at the beginning of 2023. Since then, ADMP stock has decreased by 81.8% and is now trading at $2.16.
View the best growth stocks for 2023 here.

Adamis Pharmaceuticals saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 17,600 shares, a decrease of 97.8% from the April 30th total of 799,900 shares. Based on an average daily trading volume, of 33,700 shares, the short-interest ratio is presently 0.5 days.
View Adamis Pharmaceuticals' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our ADMP earnings forecast.

Adamis Pharmaceuticals Co. (NASDAQ:ADMP) issued its quarterly earnings results on Thursday, March, 31st. The specialty pharmaceutical company reported ($4.20) EPS for the quarter, missing the consensus estimate of ($2.80) by $1.40. Adamis Pharmaceuticals had a negative net margin of 495.95% and a negative trailing twelve-month return on equity of 420.53%. During the same quarter in the previous year, the firm earned ($11.20) EPS.

Adamis Pharmaceuticals shares reverse split on the morning of Monday, May 22nd 2023. The 1-70 reverse split was announced on Monday, May 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Adamis Pharmaceuticals investors own include Trevena (TRVN), Amarin (AMRN), Sorrento Therapeutics (SRNE), Verastem (VSTM), Dynavax Technologies (DVAX), Novavax (NVAX), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Agile Therapeutics (AGRX) and OPKO Health (OPK).

Adamis Pharmaceuticals trades on the NASDAQ under the ticker symbol "ADMP."

Adamis Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Armistice Capital LLC (8.71%), Simplex Trading LLC (0.00%) and HighTower Advisors LLC (0.00%). Insiders that own company stock include David C Benedicto, David J Marguglio, Dennis J Phd Carlo, Karen K Daniels, Robert O Hopkins and Ronald B Moss.
View institutional ownership trends.

Shares of ADMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ADMP stock can currently be purchased for approximately $2.16.

Adamis Pharmaceuticals (NASDAQ:ADMP) has a market capitalization of $5.38 million and generates $4.76 million in revenue each year.

The company employs 116 workers across the globe.

Adamis Pharmaceuticals' mailing address is 11682 EL CAMINO REAL SUITE 300, SAN DIEGO CA, 92130. The official website for the company is www.adamispharmaceuticals.com. The specialty pharmaceutical company can be reached via phone at (858) 997-2400 or via email at mflather@adamispharma.com.